Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
12201
12202
12203
12204
12205
12206
12207
12208
12209
12210
12211
12212
12213
12214
12215
12216
12217
12218
12219
12220
12221
12222
12223
12224
12225
12226
12227
12228
12229
12230
12231
12232
12233
12234
12235
12236
12237
12238
12239
12240
12241
12242
12243
12244
12245
12246
12247
12248
12249
12250
12251
12252
12253
12254
12255
12256
12257
12258
12259
12260
12261
12262
12263
12264
12265
12266
12267
12268
12269
12270
12271
12272
12273
12274
12275
12276
12277
12278
12279
12280
12281
12282
12283
12284
12285
12286
12287
12288
12289
12290
12291
12292
12293
12294
12295
12296
12297
12298
12299
12300
12301
12302
12303
12304
12305
12306
12307
12308
12309
12310
12311
12312
12313
12314
12315
12316
12317
12318
12319
12320
12321
12322
12323
12324
12325
12326
12327
12328
12329
12330
12331
12332
12333
12334
12335
12336
12337
12338
12339
12340
12341
12342
12343
12344
12345
12346
12347
12348
12349
12350
12351
12352
12353
12354
12355
12356
12357
12358
12359
12360
12361
12362
12363
12364
12365
12366
12367
12368
12369
12370
12371
12372
12373
12374
12375
12376
12377
12378
12379
12380
12381
12382
12383
12384
12385
12386
12387
12388
12389
12390
12391
12392
12393
12394
12395
12396
12397
12398
12399
12400
| UnnamedSample_HQ_transcript/60167|m.16094 | UnnamedSample_HQ_transcript/60167 | Coverage 0.705 too low. | 1b2bd5d1e9b53bf328644a1ff15e994b | 438 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 204 | 286 | 1.5E-14 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/60167|m.16094 | UnnamedSample_HQ_transcript/60167 | Coverage 0.705 too low. | 1b2bd5d1e9b53bf328644a1ff15e994b | 438 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 65 | 131 | 1.4E-13 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/60167|m.16094 | UnnamedSample_HQ_transcript/60167 | Coverage 0.705 too low. | 1b2bd5d1e9b53bf328644a1ff15e994b | 438 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 196 | 4.5E-14 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/94836|m.21931 | UnnamedSample_HQ_transcript/94836 | Unmapped. | 7d0e78ca8ba46de312df03445b425805 | 246 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 3 | 245 | 3.8E-25 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/19674|m.6780 | UnnamedSample_HQ_transcript/19674 | Identity 0.717 too low. | 22fdf6f48c7aa36c882807d5e3d884c4 | 833 | Pfam | PF02732 | ERCC4 domain | 588 | 716 | 1.1E-19 | T | 22-09-2020 | IPR006166 | ERCC4 domain |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF01794 | Ferric reductase like transmembrane component | 486 | 632 | 2.9E-25 | T | 22-09-2020 | IPR013130 | Ferric reductase transmembrane component-like domain |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF08022 | FAD-binding domain | 674 | 752 | 2.4E-16 | T | 22-09-2020 | IPR013112 | FAD-binding 8 |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF13202 | EF hand | 295 | 314 | 2.0E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF13202 | EF hand | 332 | 353 | 0.0079 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF13202 | EF hand | 153 | 173 | 0.15 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/18756|m.6519 | UnnamedSample_HQ_transcript/18756 | Coverage 0.260 too low. | a061ff221238c614e17a91053d9fc007 | 974 | Pfam | PF13202 | EF hand | 220 | 234 | 0.039 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/32959|m.10202 | UnnamedSample_HQ_transcript/32959 | Coverage 0.726 too low. | dbc43c5d7b9acd88c5f7f246f26a3d12 | 847 | Pfam | PF13476 | AAA domain | 86 | 360 | 2.2E-13 | T | 22-09-2020 | IPR038729 | Rad50/SbcC-type AAA domain |
| UnnamedSample_HQ_transcript/101563|m.22819 | UnnamedSample_HQ_transcript/101563 | Coverage 0.372 too low. | a16508df4476d408873c5a75d4f4fc7a | 161 | Pfam | PF00245 | Alkaline phosphatase | 1 | 156 | 1.2E-45 | T | 22-09-2020 | IPR001952 | Alkaline phosphatase |
| UnnamedSample_HQ_transcript/91882|m.21523 | UnnamedSample_HQ_transcript/91882 | Coverage 0.964 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/91882|m.21523 | UnnamedSample_HQ_transcript/91882 | Coverage 0.964 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/103725|m.23078 | UnnamedSample_HQ_transcript/103725 | Coverage 0.953 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/103725|m.23078 | UnnamedSample_HQ_transcript/103725 | Coverage 0.953 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/78818|m.19521 | UnnamedSample_HQ_transcript/78818 | Coverage 0.865 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/78818|m.19521 | UnnamedSample_HQ_transcript/78818 | Coverage 0.865 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/112819|m.24167 | UnnamedSample_HQ_transcript/112819 | Coverage 0.938 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/112819|m.24167 | UnnamedSample_HQ_transcript/112819 | Coverage 0.938 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/62386|m.16522 | UnnamedSample_HQ_transcript/62386 | Coverage 0.714 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/62386|m.16522 | UnnamedSample_HQ_transcript/62386 | Coverage 0.714 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/83816|m.20316 | UnnamedSample_HQ_transcript/83816 | Coverage 0.925 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/83816|m.20316 | UnnamedSample_HQ_transcript/83816 | Coverage 0.925 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/76356|m.19088 | UnnamedSample_HQ_transcript/76356 | Coverage 0.814 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/76356|m.19088 | UnnamedSample_HQ_transcript/76356 | Coverage 0.814 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/96517|m.22165 | UnnamedSample_HQ_transcript/96517 | Coverage 0.958 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF00887 | Acyl CoA binding protein | 10 | 87 | 1.5E-23 | T | 22-09-2020 | IPR000582 | Acyl-CoA-binding protein, ACBP |
| UnnamedSample_HQ_transcript/96517|m.22165 | UnnamedSample_HQ_transcript/96517 | Coverage 0.958 too low. | bd569ad3ffc680a19ec4ed486ca9dfbf | 231 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 133 | 211 | 2.2E-15 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/107848|m.23560 | UnnamedSample_HQ_transcript/107848 | Unmapped. | 8ebecc2ae284c5258858e4dd8a95c8c6 | 223 | Pfam | PF00562 | RNA polymerase Rpb2, domain 6 | 68 | 197 | 2.2E-46 | T | 22-09-2020 | IPR007120 | DNA-directed RNA polymerase, subunit 2, hybrid-binding domain |
| UnnamedSample_HQ_transcript/24800|m.8168 | UnnamedSample_HQ_transcript/24800 | Coverage 0.943 too low. | 660f7b94fb140993a042af1ab68a5f2e | 822 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 1 | 81 | 2.6E-18 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/24800|m.8168 | UnnamedSample_HQ_transcript/24800 | Coverage 0.943 too low. | 660f7b94fb140993a042af1ab68a5f2e | 822 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 83 | 557 | 2.2E-129 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/9925|m.3801 | UnnamedSample_HQ_transcript/9925 | Coverage 0.826 too low. | 3a407de18a06b6508db2ea6d11c8e934 | 181 | Pfam | PF00110 | wnt family | 1 | 181 | 6.1E-71 | T | 22-09-2020 | IPR005817 | Wnt |
| UnnamedSample_HQ_transcript/50776|m.14197 | UnnamedSample_HQ_transcript/50776 | Coverage 0.695 too low. | 47c3f6875fc7300c0ba1fa495aedadee | 243 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 28 | 233 | 7.4E-32 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/93247|m.21701 | UnnamedSample_HQ_transcript/93247 | Coverage 0.973 too low. | 06476cb35f58d8e6aff34ff306b4c892 | 135 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 1 | 122 | 4.8E-35 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/89387|m.21143 | UnnamedSample_HQ_transcript/89387 | Coverage 0.895 too low. | 06476cb35f58d8e6aff34ff306b4c892 | 135 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 1 | 122 | 4.8E-35 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/93031|m.21670 | UnnamedSample_HQ_transcript/93031 | Coverage 0.777 too low. | 52a26f2d457d779d63c11b49d319b6b9 | 332 | Pfam | PF12066 | SERRATE/Ars2, N-terminal domain | 136 | 245 | 8.2E-37 | T | 22-09-2020 | IPR021933 | SERRATE/Ars2, N-terminal |
| UnnamedSample_HQ_transcript/66699|m.17354 | UnnamedSample_HQ_transcript/66699 | Coverage 0.901 too low. | 16aff17d433a17b272d86184fc17f5e4 | 299 | Pfam | PF04503 | Single-stranded DNA binding protein, SSDP | 19 | 247 | 8.0E-63 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11858|m.4445 | UnnamedSample_HQ_transcript/11858 | Coverage 0.358 too low. | 797893d50fc2913e07f013d0aa2b920e | 1203 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 366 | 441 | 5.3E-7 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/11858|m.4445 | UnnamedSample_HQ_transcript/11858 | Coverage 0.358 too low. | 797893d50fc2913e07f013d0aa2b920e | 1203 | Pfam | PF07993 | Male sterility protein | 584 | 818 | 1.0E-52 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/11858|m.4445 | UnnamedSample_HQ_transcript/11858 | Coverage 0.358 too low. | 797893d50fc2913e07f013d0aa2b920e | 1203 | Pfam | PF00550 | Phosphopantetheine attachment site | 471 | 531 | 3.8E-14 | T | 22-09-2020 | IPR009081 | Phosphopantetheine binding ACP domain |
| UnnamedSample_HQ_transcript/11858|m.4445 | UnnamedSample_HQ_transcript/11858 | Coverage 0.358 too low. | 797893d50fc2913e07f013d0aa2b920e | 1203 | Pfam | PF00501 | AMP-binding enzyme | 1 | 357 | 1.4E-56 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/11858|m.4445 | UnnamedSample_HQ_transcript/11858 | Coverage 0.358 too low. | 797893d50fc2913e07f013d0aa2b920e | 1203 | Pfam | PF00106 | short chain dehydrogenase | 964 | 1153 | 1.1E-49 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/22809|m.7643 | UnnamedSample_HQ_transcript/22809 | Identity 0.656 too low. | 0734e06d9e0aa8411552df531d0342ca | 511 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 99 | 358 | 2.7E-67 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/22809|m.7643 | UnnamedSample_HQ_transcript/22809 | Identity 0.656 too low. | 0734e06d9e0aa8411552df531d0342ca | 511 | Pfam | PF00018 | SH3 domain | 32 | 81 | 1.9E-12 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/67179|m.17438 | UnnamedSample_HQ_transcript/67179 | Coverage 0.578 too low. | 8ebef03f75b4beade7d46ae9b8a01c27 | 372 | Pfam | PF01699 | Sodium/calcium exchanger protein | 197 | 361 | 5.4E-18 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/67179|m.17438 | UnnamedSample_HQ_transcript/67179 | Coverage 0.578 too low. | 8ebef03f75b4beade7d46ae9b8a01c27 | 372 | Pfam | PF03160 | Calx-beta domain | 2 | 99 | 2.0E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/93522|m.21738 | UnnamedSample_HQ_transcript/93522 | Coverage 0.947 too low. | 54fe53f1caf4332f0a78d908b0f6ae62 | 228 | Pfam | PF03134 | TB2/DP1, HVA22 family | 19 | 96 | 1.5E-24 | T | 22-09-2020 | IPR004345 | TB2/DP1/HVA22-related protein |
| UnnamedSample_HQ_transcript/26425|m.8581 | UnnamedSample_HQ_transcript/26425 | Coverage 0.080 too low. | e09b4bf383e12e17ff13cfa218226e22 | 740 | Pfam | PF07738 | Sad1 / UNC-like C-terminal | 607 | 737 | 2.7E-35 | T | 22-09-2020 | IPR012919 | SUN domain |
| UnnamedSample_HQ_transcript/6115|m.2579 | UnnamedSample_HQ_transcript/6115 | Coverage 0.052 too low. | e09b4bf383e12e17ff13cfa218226e22 | 740 | Pfam | PF07738 | Sad1 / UNC-like C-terminal | 607 | 737 | 2.7E-35 | T | 22-09-2020 | IPR012919 | SUN domain |
| UnnamedSample_HQ_transcript/78379|m.19442 | UnnamedSample_HQ_transcript/78379 | Identity 0.939 too low. | ba6a7a0acde920de436b1811d1606fe7 | 415 | Pfam | PF01557 | Fumarylacetoacetate (FAA) hydrolase family | 130 | 407 | 1.5E-48 | T | 22-09-2020 | IPR011234 | Fumarylacetoacetase-like, C-terminal |
| UnnamedSample_HQ_transcript/78379|m.19442 | UnnamedSample_HQ_transcript/78379 | Identity 0.939 too low. | ba6a7a0acde920de436b1811d1606fe7 | 415 | Pfam | PF09298 | Fumarylacetoacetase N-terminal | 18 | 116 | 2.4E-29 | T | 22-09-2020 | IPR015377 | Fumarylacetoacetase, N-terminal |
| UnnamedSample_HQ_transcript/53345|m.14709 | UnnamedSample_HQ_transcript/53345 | Coverage 0.802 too low. | 1e4d5622cec4c45bacaaf18d0d7919f4 | 627 | Pfam | PF00501 | AMP-binding enzyme | 109 | 578 | 2.2E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/9711|m.3732 | UnnamedSample_HQ_transcript/9711 | Identity 0.705 too low. | 7da93539810ae2d367c4b20dcabc9a4e | 1184 | Pfam | PF01753 | MYND finger | 1145 | 1182 | 5.7E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/61681|m.16386 | UnnamedSample_HQ_transcript/61681 | Identity 0.712 too low. | 0eb617261f28bc4b3fd511ad1773cf54 | 346 | Pfam | PF00199 | Catalase | 2 | 253 | 2.4E-110 | T | 22-09-2020 | IPR011614 | Catalase core domain |
| UnnamedSample_HQ_transcript/61681|m.16386 | UnnamedSample_HQ_transcript/61681 | Identity 0.712 too low. | 0eb617261f28bc4b3fd511ad1773cf54 | 346 | Pfam | PF06628 | Catalase-related immune-responsive | 279 | 340 | 1.4E-17 | T | 22-09-2020 | IPR010582 | Catalase immune-responsive domain |
| UnnamedSample_HQ_transcript/106378|m.23379 | UnnamedSample_HQ_transcript/106378 | Identity 0.626 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/86100|m.20670 | UnnamedSample_HQ_transcript/86100 | Identity 0.787 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/37542|m.11285 | UnnamedSample_HQ_transcript/37542 | Coverage 0.921 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/81070|m.19897 | UnnamedSample_HQ_transcript/81070 | Identity 0.749 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/104685|m.23195 | UnnamedSample_HQ_transcript/104685 | Identity 0.608 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/108933|m.23702 | UnnamedSample_HQ_transcript/108933 | Identity 0.660 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/109354|m.23762 | UnnamedSample_HQ_transcript/109354 | Identity 0.813 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/113521|m.24246 | UnnamedSample_HQ_transcript/113521 | Coverage 0.979 too low. | a8db37fe64874c87de45ddf96a418f5f | 219 | Pfam | PF01395 | PBP/GOBP family | 25 | 113 | 1.1E-6 | T | 22-09-2020 | IPR006170 | Pheromone/general odorant binding protein |
| UnnamedSample_HQ_transcript/12728|m.4733 | UnnamedSample_HQ_transcript/12728 | Coverage 0.701 too low. | 17f56cf908f325f68513cd4816a9f8fd | 863 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 240 | 311 | 9.7E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/12728|m.4733 | UnnamedSample_HQ_transcript/12728 | Coverage 0.701 too low. | 17f56cf908f325f68513cd4816a9f8fd | 863 | Pfam | PF12738 | twin BRCT domain | 151 | 213 | 4.5E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/12728|m.4733 | UnnamedSample_HQ_transcript/12728 | Coverage 0.701 too low. | 17f56cf908f325f68513cd4816a9f8fd | 863 | Pfam | PF00621 | RhoGEF domain | 422 | 603 | 5.6E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/53436|m.14728 | UnnamedSample_HQ_transcript/53436 | Coverage 0.375 too low. | 05f48b909a3b72bf410744b176816af6 | 551 | Pfam | PF04959 | Arsenite-resistance protein 2 | 339 | 534 | 3.2E-54 | T | 22-09-2020 | IPR007042 | SERRATE/Ars2 , C-terminal |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 1.4E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 4.9E-20 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 1060 | 1154 | 1.4E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 636 | 738 | 2.6E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 419 | 520 | 5.2E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 524 | 633 | 3.5E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 848 | 949 | 6.8E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 742 | 843 | 5.9E-23 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 954 | 1057 | 2.4E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/12695|m.4727 | UnnamedSample_HQ_transcript/12695 | Coverage 0.916 too low. | 8dec06650bfef7a34be455e3e90a890d | 1155 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 1.6E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/33977|m.10457 | UnnamedSample_HQ_transcript/33977 | Coverage 0.070 too low. | b238ac6e5fb958ddd72916e483c55f2f | 574 | Pfam | PF00083 | Sugar (and other) transporter | 113 | 545 | 6.5E-91 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/108218|m.23607 | UnnamedSample_HQ_transcript/108218 | Coverage 0.935 too low. | 96149800364b8bf3f9b3365fb85abe19 | 201 | Pfam | PF03098 | Animal haem peroxidase | 1 | 172 | 7.8E-63 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/52372|m.14522 | UnnamedSample_HQ_transcript/52372 | Coverage 0.957 too low. | 9e9c414e1e42a10a4b686f5e0e41fd9b | 530 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 56 | 291 | 2.2E-61 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/31132|m.9743 | UnnamedSample_HQ_transcript/31132 | Coverage 0.899 too low. | 77ead0c2f25dd69c344ddc6135c539c1 | 365 | Pfam | PF00682 | HMGL-like | 1 | 270 | 2.2E-28 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/31132|m.9743 | UnnamedSample_HQ_transcript/31132 | Coverage 0.899 too low. | 77ead0c2f25dd69c344ddc6135c539c1 | 365 | Pfam | PF02436 | Conserved carboxylase domain | 296 | 345 | 3.9E-18 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/52374|m.14523 | UnnamedSample_HQ_transcript/52374 | Coverage 0.068 too low. | 2448a5229adeacf2087c813b4b016fbc | 634 | Pfam | PF13017 | piRNA pathway germ-plasm component | 2 | 149 | 3.6E-11 | T | 22-09-2020 | IPR024970 | Maelstrom domain |
| UnnamedSample_HQ_transcript/19265|m.6653 | UnnamedSample_HQ_transcript/19265 | Coverage 0.898 too low. | 04c084f85810db5461833ffdd9002781 | 515 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 488 | 6.4E-51 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/38135|m.11431 | UnnamedSample_HQ_transcript/38135 | Coverage 0.860 too low. | 04c084f85810db5461833ffdd9002781 | 515 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 488 | 6.4E-51 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/51944|m.14445 | UnnamedSample_HQ_transcript/51944 | Identity 0.937 too low. | 04c084f85810db5461833ffdd9002781 | 515 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 488 | 6.4E-51 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/37687|m.11318 | UnnamedSample_HQ_transcript/37687 | Coverage 0.886 too low. | 04c084f85810db5461833ffdd9002781 | 515 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 488 | 6.4E-51 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/44364|m.12785 | UnnamedSample_HQ_transcript/44364 | Coverage 0.927 too low. | 04c084f85810db5461833ffdd9002781 | 515 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 488 | 6.4E-51 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/9552|m.3691 | UnnamedSample_HQ_transcript/9552 | Coverage 0.754 too low. | aa97f5bf25138b2d3f4a6b1fb008decd | 784 | Pfam | PF07534 | TLD | 648 | 783 | 2.2E-33 | T | 22-09-2020 | IPR006571 | TLDc domain |
| UnnamedSample_HQ_transcript/57337|m.15510 | UnnamedSample_HQ_transcript/57337 | Coverage 0.359 too low. | bbf13799380f476b62330b24b2f979ee | 453 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF07686 | Immunoglobulin V-set domain | 27 | 111 | 1.8E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 253 | 331 | 2.9E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF00047 | Immunoglobulin domain | 156 | 233 | 3.3E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13895 | Immunoglobulin domain | 554 | 628 | 3.0E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 839 | 908 | 5.0E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8760|m.3439 | UnnamedSample_HQ_transcript/8760 | Coverage 0.143 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 352 | 428 | 3.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF07686 | Immunoglobulin V-set domain | 27 | 111 | 1.8E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 253 | 331 | 2.9E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF00047 | Immunoglobulin domain | 156 | 233 | 3.3E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13895 | Immunoglobulin domain | 554 | 628 | 3.0E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 839 | 908 | 5.0E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12528|m.4673 | UnnamedSample_HQ_transcript/12528 | Coverage 0.057 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 352 | 428 | 3.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF07686 | Immunoglobulin V-set domain | 27 | 111 | 1.8E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 253 | 331 | 2.9E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF00047 | Immunoglobulin domain | 156 | 233 | 3.3E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13895 | Immunoglobulin domain | 554 | 628 | 3.0E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 839 | 908 | 5.0E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9095|m.3541 | UnnamedSample_HQ_transcript/9095 | Coverage 0.144 too low. | aeb7e9f864b1febbec05ec7553911f0f | 1063 | Pfam | PF13927 | Immunoglobulin domain | 352 | 428 | 3.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/112200|m.24103 | UnnamedSample_HQ_transcript/112200 | Coverage 0.970 too low. | 8136db80288ccc0c042d8c3b19453831 | 185 | Pfam | PF00153 | Mitochondrial carrier protein | 1 | 65 | 3.0E-11 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/112200|m.24103 | UnnamedSample_HQ_transcript/112200 | Coverage 0.970 too low. | 8136db80288ccc0c042d8c3b19453831 | 185 | Pfam | PF00153 | Mitochondrial carrier protein | 81 | 158 | 1.3E-8 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/58032|m.15659 | UnnamedSample_HQ_transcript/58032 | Coverage 0.975 too low. | 137d7d06a3dd6efc7eb2b5e92593d1d4 | 376 | Pfam | PF12146 | Serine aminopeptidase, S33 | 144 | 260 | 4.3E-12 | T | 22-09-2020 | IPR022742 | Serine aminopeptidase, S33 |
| UnnamedSample_HQ_transcript/57569|m.15559 | UnnamedSample_HQ_transcript/57569 | Coverage 0.979 too low. | 137d7d06a3dd6efc7eb2b5e92593d1d4 | 376 | Pfam | PF12146 | Serine aminopeptidase, S33 | 144 | 260 | 4.3E-12 | T | 22-09-2020 | IPR022742 | Serine aminopeptidase, S33 |
| UnnamedSample_HQ_transcript/55574|m.15149 | UnnamedSample_HQ_transcript/55574 | Identity 0.911 too low. | 25ba501ac1398c5df733d7b5b8d31d97 | 299 | Pfam | PF11979 | Domain of unknown function (DUF3480) | 1 | 273 | 9.2E-102 | T | 22-09-2020 | IPR022557 | Domain of unknown function DUF3480 |
| UnnamedSample_HQ_transcript/76091|m.19041 | UnnamedSample_HQ_transcript/76091 | Coverage 0.564 too low. | 3eea3d65580a691315db6a361fb3cf1c | 528 | Pfam | PF01380 | SIS domain | 354 | 482 | 1.3E-34 | T | 22-09-2020 | IPR001347 | Sugar isomerase (SIS) |
| UnnamedSample_HQ_transcript/76091|m.19041 | UnnamedSample_HQ_transcript/76091 | Coverage 0.564 too low. | 3eea3d65580a691315db6a361fb3cf1c | 528 | Pfam | PF13522 | Glutamine amidotransferase domain | 78 | 193 | 3.4E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/970|m.619 | UnnamedSample_HQ_transcript/970 | Coverage 0.071 too low. | ea90e9594e773f4623e37a01f1aa71fc | 1129 | Pfam | PF14765 | Polyketide synthase dehydratase | 36 | 202 | 1.9E-6 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/970|m.619 | UnnamedSample_HQ_transcript/970 | Coverage 0.071 too low. | ea90e9594e773f4623e37a01f1aa71fc | 1129 | Pfam | PF08659 | KR domain | 995 | 1118 | 1.4E-18 | T | 22-09-2020 | IPR013968 | Polyketide synthase, ketoreductase domain |
| UnnamedSample_HQ_transcript/15909|m.5680 | UnnamedSample_HQ_transcript/15909 | Coverage 0.834 too low. | 3e7e9dbf3af7071a0235dac22b9710db | 927 | Pfam | PF00018 | SH3 domain | 32 | 81 | 4.1E-12 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/15909|m.5680 | UnnamedSample_HQ_transcript/15909 | Coverage 0.834 too low. | 3e7e9dbf3af7071a0235dac22b9710db | 927 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 99 | 358 | 9.8E-67 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/23468|m.7799 | UnnamedSample_HQ_transcript/23468 | Identity 0.949 too low. | e2afdfdce7f7d5763d281681c7ed5ca9 | 859 | Pfam | PF00790 | VHS domain | 7 | 138 | 2.0E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/23468|m.7799 | UnnamedSample_HQ_transcript/23468 | Identity 0.949 too low. | e2afdfdce7f7d5763d281681c7ed5ca9 | 859 | Pfam | PF01363 | FYVE zinc finger | 163 | 219 | 7.3E-17 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/23468|m.7799 | UnnamedSample_HQ_transcript/23468 | Identity 0.949 too low. | e2afdfdce7f7d5763d281681c7ed5ca9 | 859 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 427 | 519 | 5.0E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/22132|m.7467 | UnnamedSample_HQ_transcript/22132 | Coverage 0.105 too low. | d24629aee047297fc169e7cab39f9fde | 650 | Pfam | PF00069 | Protein kinase domain | 51 | 305 | 1.4E-73 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/73378|m.18540 | UnnamedSample_HQ_transcript/73378 | Coverage 0.303 too low. | 4b5973f70a7d92e2904582feb5f6e8bb | 196 | Pfam | PF13639 | Ring finger domain | 80 | 122 | 7.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/84856|m.20474 | UnnamedSample_HQ_transcript/84856 | Identity 0.724 too low. | ecb3d751aef6a6eb44faaf77a3617860 | 215 | Pfam | PF00183 | Hsp90 protein | 1 | 195 | 3.7E-75 | T | 22-09-2020 | IPR001404 | Heat shock protein Hsp90 family |
| UnnamedSample_HQ_transcript/16564|m.5880 | UnnamedSample_HQ_transcript/16564 | Coverage 0.796 too low. | c1ffbf56f06692e108407d5968cf8f4d | 748 | Pfam | PF07810 | TMC domain | 501 | 610 | 1.8E-35 | T | 22-09-2020 | IPR012496 | TMC domain |
| UnnamedSample_HQ_transcript/21178|m.7194 | UnnamedSample_HQ_transcript/21178 | Coverage 0.572 too low. | 5d5329f426ca95164f115d436e2933bf | 820 | Pfam | PF00439 | Bromodomain | 353 | 433 | 3.1E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/20098|m.6901 | UnnamedSample_HQ_transcript/20098 | Coverage 0.100 too low. | 0141b0450c340b67df6320c96eb716a4 | 676 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 6.6E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/20098|m.6901 | UnnamedSample_HQ_transcript/20098 | Coverage 0.100 too low. | 0141b0450c340b67df6320c96eb716a4 | 676 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 639 | 1.4E-17 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/20098|m.6901 | UnnamedSample_HQ_transcript/20098 | Coverage 0.100 too low. | 0141b0450c340b67df6320c96eb716a4 | 676 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 5.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/78677|m.19495 | UnnamedSample_HQ_transcript/78677 | Coverage 0.972 too low. | fb3b9e7b22cdcdd51ef4d8f2ae89cd88 | 469 | Pfam | PF00012 | Hsp70 protein | 34 | 421 | 7.4E-90 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/2667|m.1308 | UnnamedSample_HQ_transcript/2667 | Coverage 0.306 too low. | 9435dba6990f62a9f4155b4dd7691519 | 673 | Pfam | PF19056 | WD40 repeated domain | 333 | 548 | 1.8E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/71726|m.18255 | UnnamedSample_HQ_transcript/71726 | Coverage 0.833 too low. | 5ca8f97ff595e502ef067296cf502ea9 | 530 | Pfam | PF08790 | LYAR-type C2HC zinc finger | 35 | 62 | 9.6E-11 | T | 22-09-2020 | IPR014898 | Zinc finger, C2H2, LYAR-type |
| UnnamedSample_HQ_transcript/44665|m.12846 | UnnamedSample_HQ_transcript/44665 | Coverage 0.943 too low. | 820b0352554b451e96e93dea3cd729f8 | 400 | Pfam | PF03250 | Tropomodulin | 36 | 175 | 6.0E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/74009|m.18641 | UnnamedSample_HQ_transcript/74009 | Coverage 0.935 too low. | 077224e5b4581cbbe559bf315f6c9cb4 | 501 | Pfam | PF00069 | Protein kinase domain | 217 | 494 | 1.3E-36 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/74009|m.18641 | UnnamedSample_HQ_transcript/74009 | Coverage 0.935 too low. | 077224e5b4581cbbe559bf315f6c9cb4 | 501 | Pfam | PF01064 | Activin types I and II receptor domain | 60 | 131 | 3.7E-5 | T | 22-09-2020 | IPR000472 | Activin types I and II receptor domain |
| UnnamedSample_HQ_transcript/76479|m.19114 | UnnamedSample_HQ_transcript/76479 | Identity 0.927 too low. | 7ced8e6a58581a92bfb8739c39e4295d | 426 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 34 | 426 | 8.1E-128 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/88982|m.21082 | UnnamedSample_HQ_transcript/88982 | Coverage 0.986 too low. | fd2dc7d21d3dfff95e267671f4aa7b5d | 351 | Pfam | PF13927 | Immunoglobulin domain | 75 | 154 | 5.1E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/88210|m.20970 | UnnamedSample_HQ_transcript/88210 | Coverage 0.660 too low. | 4c890f3f963c69309b056394560e7917 | 421 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 114 | 421 | 4.3E-65 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/20307|m.6951 | UnnamedSample_HQ_transcript/20307 | Coverage 0.857 too low. | 75aa4703785c493111d037998960f11d | 172 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 1 | 171 | 7.2E-46 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/68438|m.17656 | UnnamedSample_HQ_transcript/68438 | Coverage 0.840 too low. | d40a4d8d4264a4faa88b963509a3a877 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 25 | 342 | 4.7E-20 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/59437|m.15932 | UnnamedSample_HQ_transcript/59437 | Coverage 0.903 too low. | d40a4d8d4264a4faa88b963509a3a877 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 25 | 342 | 4.7E-20 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/54738|m.14992 | UnnamedSample_HQ_transcript/54738 | Identity 0.737 too low. | d40a4d8d4264a4faa88b963509a3a877 | 475 | Pfam | PF09820 | Predicted AAA-ATPase | 25 | 342 | 4.7E-20 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/74200|m.18683 | UnnamedSample_HQ_transcript/74200 | Coverage 0.399 too low. | fef10cce7208d868ffa3526481ed17c2 | 467 | Pfam | PF15361 | Resistance to inhibitors of cholinesterase homologue 3 | 209 | 331 | 1.5E-10 | T | 22-09-2020 | IPR032763 | Resistance to inhibitors of cholinesterase protein 3, N-terminal |
| UnnamedSample_HQ_transcript/14348|m.5213 | UnnamedSample_HQ_transcript/14348 | Identity 0.910 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 3.6E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/14348|m.5213 | UnnamedSample_HQ_transcript/14348 | Identity 0.910 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02172 | KIX domain | 792 | 837 | 1.5E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/14348|m.5213 | UnnamedSample_HQ_transcript/14348 | Identity 0.910 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02172 | KIX domain | 727 | 756 | 7.3E-6 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/11998|m.4494 | UnnamedSample_HQ_transcript/11998 | Identity 0.915 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 3.6E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/11998|m.4494 | UnnamedSample_HQ_transcript/11998 | Identity 0.915 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02172 | KIX domain | 792 | 837 | 1.5E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/11998|m.4494 | UnnamedSample_HQ_transcript/11998 | Identity 0.915 too low. | df5c73c65e9f9da575a3c8c81af4bd7d | 1156 | Pfam | PF02172 | KIX domain | 727 | 756 | 7.3E-6 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/38811|m.11578 | UnnamedSample_HQ_transcript/38811 | Identity 0.940 too low. | 14dd6872387444f4914331c6268ffd71 | 638 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 206 | 298 | 3.2E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 824 | 914 | 5.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 633 | 723 | 2.0E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1696 | 1768 | 1.5E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1590 | 1674 | 4.7E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1024 | 1103 | 1.2E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 250 | 340 | 4.7E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1777 | 1862 | 1.7E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 347 | 430 | 1.6E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1498 | 1579 | 3.7E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1216 | 1298 | 1.8E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1152 | 1206 | 2.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 1395 | 1481 | 9.8E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 921 | 1012 | 2.6E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 731 | 817 | 8.6E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 151 | 243 | 7.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 538 | 625 | 4.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 51 | 143 | 1.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/801|m.543 | UnnamedSample_HQ_transcript/801 | Coverage 0.539 too low. | f1984e5a2b16643cda0517a6051e4248 | 1961 | Pfam | PF00630 | Filamin/ABP280 repeat | 442 | 530 | 1.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/67994|m.17575 | UnnamedSample_HQ_transcript/67994 | Identity 0.819 too low. | f48e079cfc28204d9ba6aefdce7c6870 | 463 | Pfam | PF02958 | Ecdysteroid kinase | 96 | 365 | 4.6E-52 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/88040|m.20944 | UnnamedSample_HQ_transcript/88040 | Coverage 0.210 too low. | 026f02fa23f4b51924c380f4bb068d4d | 384 | Pfam | PF00135 | Carboxylesterase family | 27 | 371 | 1.0E-102 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/66438|m.17298 | UnnamedSample_HQ_transcript/66438 | Coverage 0.857 too low. | e762647200fc5101b5bc2368818ee58e | 562 | Pfam | PF00012 | Hsp70 protein | 5 | 561 | 2.3E-220 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/101252|m.22786 | UnnamedSample_HQ_transcript/101252 | Coverage 0.250 too low. | f37b4854a220cf86e5db0284133ec7c5 | 274 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.4E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/101127|m.22765 | UnnamedSample_HQ_transcript/101127 | Coverage 0.252 too low. | f37b4854a220cf86e5db0284133ec7c5 | 274 | Pfam | PF00650 | CRAL/TRIO domain | 110 | 263 | 2.4E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/19583|m.6755 | UnnamedSample_HQ_transcript/19583 | Coverage 0.567 too low. | 3d7da559f26b15648b439cd7c2e3a5c1 | 648 | Pfam | PF08441 | Integrin alpha | 255 | 636 | 1.8E-66 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
| UnnamedSample_HQ_transcript/19583|m.6755 | UnnamedSample_HQ_transcript/19583 | Coverage 0.567 too low. | 3d7da559f26b15648b439cd7c2e3a5c1 | 648 | Pfam | PF01839 | FG-GAP repeat | 68 | 108 | 1.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/19583|m.6755 | UnnamedSample_HQ_transcript/19583 | Coverage 0.567 too low. | 3d7da559f26b15648b439cd7c2e3a5c1 | 648 | Pfam | PF01839 | FG-GAP repeat | 146 | 189 | 7.0E-7 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/31621|m.9858 | UnnamedSample_HQ_transcript/31621 | Coverage 0.193 too low. | 0f832040558575117b51614a116da40d | 570 | Pfam | PF10408 | Ubiquitin elongating factor core | 1 | 476 | 5.9E-127 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/31621|m.9858 | UnnamedSample_HQ_transcript/31621 | Coverage 0.193 too low. | 0f832040558575117b51614a116da40d | 570 | Pfam | PF04564 | U-box domain | 493 | 564 | 1.9E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/36390|m.11021 | UnnamedSample_HQ_transcript/36390 | Coverage 0.152 too low. | 0f832040558575117b51614a116da40d | 570 | Pfam | PF10408 | Ubiquitin elongating factor core | 1 | 476 | 5.9E-127 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/36390|m.11021 | UnnamedSample_HQ_transcript/36390 | Coverage 0.152 too low. | 0f832040558575117b51614a116da40d | 570 | Pfam | PF04564 | U-box domain | 493 | 564 | 1.9E-30 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/4932|m.2166 | UnnamedSample_HQ_transcript/4932 | Coverage 0.085 too low. | e1f936d2c0d1dc34cd2d04d1ad97a09b | 1261 | Pfam | PF18436 | Helical box domain of E3 ubiquitin-protein ligase HECW1 | 669 | 731 | 3.0E-21 | T | 22-09-2020 | IPR040524 | E3 ubiquitin-protein ligase HECW1, helical box domain |
| UnnamedSample_HQ_transcript/4932|m.2166 | UnnamedSample_HQ_transcript/4932 | Coverage 0.085 too low. | e1f936d2c0d1dc34cd2d04d1ad97a09b | 1261 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 955 | 1260 | 2.3E-101 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/4932|m.2166 | UnnamedSample_HQ_transcript/4932 | Coverage 0.085 too low. | e1f936d2c0d1dc34cd2d04d1ad97a09b | 1261 | Pfam | PF00397 | WW domain | 574 | 603 | 9.1E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/10521|m.3995 | UnnamedSample_HQ_transcript/10521 | Identity 0.762 too low. | 9daebbad371877213aac3403869b5c03 | 1077 | Pfam | PF00266 | Aminotransferase class-V | 31 | 231 | 1.7E-9 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/10521|m.3995 | UnnamedSample_HQ_transcript/10521 | Identity 0.762 too low. | 9daebbad371877213aac3403869b5c03 | 1077 | Pfam | PF01171 | PP-loop family | 926 | 1076 | 2.3E-9 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/15286|m.5494 | UnnamedSample_HQ_transcript/15286 | Coverage 0.347 too low. | 98f345816a056a54a2cf9fa6fc84876d | 929 | Pfam | PF01030 | Receptor L domain | 166 | 277 | 1.3E-26 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/15286|m.5494 | UnnamedSample_HQ_transcript/15286 | Coverage 0.347 too low. | 98f345816a056a54a2cf9fa6fc84876d | 929 | Pfam | PF01030 | Receptor L domain | 489 | 602 | 2.5E-25 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/15286|m.5494 | UnnamedSample_HQ_transcript/15286 | Coverage 0.347 too low. | 98f345816a056a54a2cf9fa6fc84876d | 929 | Pfam | PF00757 | Furin-like cysteine rich region | 307 | 450 | 1.9E-22 | T | 22-09-2020 | IPR006211 | Furin-like cysteine-rich domain |
| UnnamedSample_HQ_transcript/72574|m.18397 | UnnamedSample_HQ_transcript/72574 | Coverage 0.701 too low. | 7d959c9d6b994ed30c8fb05cfb0470a6 | 489 | Pfam | PF16040 | Domain of unknown function (DUF4792) | 98 | 167 | 1.2E-21 | T | 22-09-2020 | IPR032008 | Domain of unknown function DUF4792 |
| UnnamedSample_HQ_transcript/54590|m.14963 | UnnamedSample_HQ_transcript/54590 | Coverage 0.682 too low. | 8abfec49ce82bdb42439b7669e0117a2 | 555 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 123 | 259 | 3.9E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/54590|m.14963 | UnnamedSample_HQ_transcript/54590 | Coverage 0.682 too low. | 8abfec49ce82bdb42439b7669e0117a2 | 555 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 341 | 548 | 1.8E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/25297|m.8287 | UnnamedSample_HQ_transcript/25297 | Coverage 0.036 too low. | 0cae591c39a8007db64d3b736dcb73a9 | 177 | Pfam | PF07809 | RTP801 C-terminal region | 57 | 172 | 9.6E-45 | T | 22-09-2020 | IPR012918 | RTP801-like |
| UnnamedSample_HQ_transcript/4475|m.1989 | UnnamedSample_HQ_transcript/4475 | Coverage 0.081 too low. | ef6c1e196c95f46a8e58672a762c58a6 | 785 | Pfam | PF00397 | WW domain | 130 | 159 | 5.3E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/4475|m.1989 | UnnamedSample_HQ_transcript/4475 | Coverage 0.081 too low. | ef6c1e196c95f46a8e58672a762c58a6 | 785 | Pfam | PF18436 | Helical box domain of E3 ubiquitin-protein ligase HECW1 | 225 | 287 | 1.6E-21 | T | 22-09-2020 | IPR040524 | E3 ubiquitin-protein ligase HECW1, helical box domain |
| UnnamedSample_HQ_transcript/4475|m.1989 | UnnamedSample_HQ_transcript/4475 | Coverage 0.081 too low. | ef6c1e196c95f46a8e58672a762c58a6 | 785 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 511 | 781 | 2.6E-81 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/71269|m.18165 | UnnamedSample_HQ_transcript/71269 | Coverage 0.220 too low. | 3c8b2cc86f9b6a982e600dbb8c989ddc | 510 | Pfam | PF00999 | Sodium/hydrogen exchanger family | 109 | 495 | 9.1E-29 | T | 22-09-2020 | IPR006153 | Cation/H+ exchanger |
| UnnamedSample_HQ_transcript/73469|m.18563 | UnnamedSample_HQ_transcript/73469 | Coverage 0.197 too low. | 3c8b2cc86f9b6a982e600dbb8c989ddc | 510 | Pfam | PF00999 | Sodium/hydrogen exchanger family | 109 | 495 | 9.1E-29 | T | 22-09-2020 | IPR006153 | Cation/H+ exchanger |
| UnnamedSample_HQ_transcript/38879|m.11595 | UnnamedSample_HQ_transcript/38879 | Coverage 0.736 too low. | 58d3d9629fb96156bd7aba3e014a1357 | 588 | Pfam | PF00780 | CNH domain | 281 | 558 | 2.5E-62 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
